The goal of the present study was to identify synthetic lethal interactions between proteases and the PI3K/mTOR pathway inhibitors BKM and BEZ in murine breast cancer cells by employing synthetic lethality screens. The gene discussed is PIK3CA; the disease is breast cancer.